Propofol
- Generic Name
- Propofol
- Brand Names
- Diprivan
- Drug Type
- Small Molecule
- Chemical Formula
- C12H18O
- CAS Number
- 2078-54-8
- Unique Ingredient Identifier
- YI7VU623SF
- Background
Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. ...
- Indication
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
- Associated Conditions
- -
- Associated Therapies
- Induction of anesthesia therapy, Maintenance of anesthesia therapy, Monitored anesthesia care sedation, Sedative therapy
Effects of Propofol on Oxidative Stress and Liver Regeneration After Partial Hepatectomy
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2012-06-26
- Lead Sponsor
- Rennes University Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT00219856
- Locations
- 🇫🇷
Surgical Intensive Care Unit - Rennes University Hospital, Rennes, France
Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2010-06-11
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT00209521
Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 168
- Registration Number
- NCT00187135
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-10-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 224
- Registration Number
- NCT00158873
- Locations
- 🇳🇱
GSK Investigational Site, Zwolle, Netherlands
Effect of Affective Content on Drug Induced Amnesia of Episodic Memory
- Conditions
- Interventions
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2015-12-24
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 79
- Registration Number
- NCT00142493
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- FDA Office of Orphan Products Development
- Target Recruit Count
- 120
- Registration Number
- NCT00004424
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.